
PujaUmaretiya
@pujaumaretiya
Current Pediatric Heme/Onc and Postdoctoral Research Fellow @DanaFarber | Palliative Care trained | Tweets are my own
ID: 1389626589630111746
04-05-2021 17:03:00
62 Tweet
113 Followers
95 Following

#ASPHO2022 off to a great start (IMO)! Got to work with this wonderful group of humans for the pre-con session: “Clinical Trials in AYA oncology: Diversity, Equity, Inclusion, and a Collaborative Approach” Jeffrey Edwards, MD MPH AaronYeo PujaUmaretiya


Had so much fun dreaming and scheming with this group on how to make the world of clinical trials more equitable! 24 hours in Pittsburgh well spent 😊AaronYeo Stefanie Thomas, MD Jeffrey Edwards, MD MPH



Had an amazing experience today with Eric J. Small, MD, FASCO and Julie Gralow today in the #ASCO2022 press program! Loved seeing the work addressing #disparities and #equity in #cancer care by @JennyGuadamuz PujaUmaretiya @faceofstage4 (a patient-researcher!)! Big shoutout to ASCO media team!


Cancer survival shouldn't be determined by race, ethnicity, or income. We're eager to see PujaUmaretiya Kira Bona, MD, MPH Dana-Farber share these findings on the stage at #ASCO2022 & continue working toward equity in #cancercare. hms.harvard.edu/news/children-…

Today at #ASCO22: Race, ethnicity, and poverty linked to worse outcomes in children with #neuroblastoma, despite being enrolled in clinical trials. PujaUmaretiya of Dana-Farber/Boston Children's presenting at 5:24pm ET in the Pediatric Oncology Oral Abstract Session ➡️ ms.spr.ly/6013bwBTS


Abstract 10005 #asco22 - Racial, ethnic and socioeconomic survival disparities among kids with HR neuroblastoma treated on upfront Children’s Oncology Group trials OS affected by #SDOH and more work is planned to better understand #ChildhoodCancer #pedcsm #neuroblastoma #healthequity


Absolutely fantastic presentations by rockstars @Lenkai12 & PujaUmaretiya examining disparities in #osteosarcoma & #neuroblastoma, respectively ASCO #ASCO22 👏 Such incredible & ⬆️ needed work. The future of research in #ChildhoodCancer is bright! 🌟 🌟 Cc: Kira Bona, MD, MPH


#ASCO - Nice work on socioeconomic, racial and ethnic disparities in high-risk neuroblastoma with worse outcomes in Hispanic patients presented by PujaUmaretiya

Kudos and thank you 👏👏👏to presenters @Lenkai12 & PujaUmaretiya, as well as discussant Justine Kahn MD, MS, for explicitly calling out **systemic racism** as driving outcome disparities in #ChildhoodCancer #ASCO22 #ASCO2022


Check out our new prospective pediatric study of pyloric Botox in Neurogastro & Motil ! 64% of kids had improved nausea or vomiting after Botox, and pyloric EndoFLIP didn’t predict response. Grateful to the best mentorship team! Rachel Rosen Samuel Nurko onlinelibrary.wiley.com/doi/full/10.11…

Rooftop summer series 2022 continues! Pictured: delicious Lucy Ethiopian Cafe, hand sanitizer, Jessica Tsai, MD, PhD and PujaUmaretiya laughing at an anecdote from my wife about my inability to travel alone, my creep face. Love these guys and what they stand for. I need photography lessons.❤️



Read the powerful words of Ayesha Dholakia, MD regarding gun violence. "In the 10 years since, the unthinkable has happened again, and again, begging the question: when did the murder of innocent children no longer qualify as unthinkable?" @the_BMC @BCRP wbur.org/cognoscenti/20…

Sonia Malhotra,MD,MS Why & when #singlesite studies are essential: 1. Pilot data for proof of concept 2. Early career pilot work 3. Rural, difficult to reach populations-establishing trust 4. Rapid cycle QI “Both…and”…a more logical & #pragmatic approach.

